Morrison & Foerster LLP
Antibodies directed to IL-17A/IL-17F heterodimers
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F). Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, specific antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.
Genentech, Inc.
A A A A A A A C A A C A A C A A A C A A A A C G C C A A C C A A Y C A A G A A A C A C A G C C A A A A C A A A A C
A61P A61P A61P A61P A61P A61P A61P C07K A61P A61P C07K A61P A61P C07K A61P A61P A61K C07K A61P A61P A61P A61P C07K G01N C07K C07K A61P A61P C07K C07K A61K A61P Y02A C07K A61P A61P G01N A61P A61P A61P C07K A61P C07K A61P G01N C07K C07K A61P A61P A61P A61P C07K A61K A61P A61P A61P C07K
inventional inventional inventional inventional inventional inventional inventional additional inventional inventional additional inventional inventional additional inventional inventional additional additional inventional inventional inventional inventional additional inventional inventional additional inventional inventional additional additional inventional inventional additional additional inventional inventional additional inventional inventional inventional additional inventional additional inventional additional additional additional inventional inventional inventional inventional inventional additional inventional inventional inventional additional
Yan Philip E. James M. Austin L. David P.
Wu Hass Lee Gurney Arnott